spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  angina pectoris 

 HSMN NewsFeed - 11 Dec 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2018
Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Feb 2018
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer(TM) Procedure for Treatment of Refractory Angina
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 5 Sep 2017
Neovasc's Reducer System Reviewed in European Heart Journal
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 4 Apr 2016
ANI Pharmaceuticals Closes Acquisition of Inderal(R) LA Assets
Biopharmaceuticals Cardiology Acquisitions
 HSMN NewsFeed - 16 Sep 2015
Espero Pharmaceuticals Announces Exclusive Licensing and Distribution Agreement
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 24 Apr 2014
Endo Acquires Rights to Sumavel(R) DosePro(R)
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 5 Feb 2013
ZALTRAP(R) (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Nov 2012
ZYTIGA(R) Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Aug 2011
OPKO Invests in Cardiac Device Company
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Jun 2011
Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent(R) Drug-Eluting Coronary Stent Based on Early Clinical Data
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Mar 2011
Data Presented at AAAAI Annual Meeting Further Support the Safety and Efficacy of FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2011
Shire Files Complete Response to FDA's Not Approvable Letter for FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Nov 2010
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 23 Feb 2010
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 29 Jan 2010
Teva UK Limited Launches Lercanidipine Hydrochloride Film-Coated Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 18 May 2009
AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2009
CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Mar 2009
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
Devices Neurology Cardiology Regulatory
 HSMN NewsFeed - 20 Feb 2009
UCB to divest Equasym(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 28 Jan 2009
CV Therapeutics Statement on Unsolicited Proposal From Astellas
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 6 Nov 2008
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 12 Sep 2008
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 14 Aug 2008
CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 21 Jul 2008
Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 4 Jun 2008
LifeWatch Corp. Parent Company, Card Guard AG Receives Full FDA Clearance for Next-Generation LifeStar ACT III Platinum System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 15 May 2008
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Apr 2008
European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Biopharmaceuticals
 HSMN NewsFeed - 5 Mar 2008
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Feb 2008
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 15 Oct 2007
Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease
Diagnostics Cardiology
 HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Biopharmaceuticals
 HSMN NewsFeed - 13 Aug 2007
Actavis Receives Approval for Generic Inderal LA Capsules in the U.S.
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Aug 2007
NovaDel Announces Sublicense Agreement for Zensana(TM)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 8 Jun 2007
Salix Pharmaceuticals Announces Imminent Launch of Visiclear(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 18 May 2007
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Mar 2007
Novartis Suspends US Marketing and Sales of Zelnorm(R) in Response to Request from FDA
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 20 Mar 2007
MGI PHARMA Announces Positive Results from a Pivotal Phase 3 Study of Aquavan(R) Injection in Patients Undergoing Bronchoscopy
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2007
Par Pharmaceutical Receives Approval of Generic Inderal-LA(R)
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 16 Jan 2007
Enrollment Completed in Pivotal Phase III Study Comparing Prasugrel to Clopidogrel in Patients With Acute Coronary Syndrome
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Jan 2007
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 Dec 2006
Cardium's Generx Advances to Phase 3 Following Meeting With FDA
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Nov 2006
Par Pharmaceutical Begins Shipment of Generic TOPROL-XL(R)
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 3 Nov 2006
NovaDel Pharma Receives FDA Approval of NitroMist(TM)
Biopharmaceuticals Drug Delivery FDA Cardiology
 HSMN NewsFeed - 23 Oct 2006
New Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Oct 2006
Salix Pharmaceuticals Reports American College of Gastroenterology Update
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 5 Jun 2006
Cardium Reports Meta-Analysis of Angiogenic Gene Therapy Studies Shows Positive Effects in Men and Women With Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Jun 2006
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2006
FDA Accepts Submission for NitroMist as Complete Response
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 May 2006
UCB Completes Mutual Recognition Procedure for Equasym(TM) XL
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 May 2006
Federal Appeals Court Rules in Cardium's Favor Over Boston Scientific and Arch Development on Patents for the Treatment of Heart Disease
Devices Cardiology Litigation
 HSMN NewsFeed - 29 Mar 2006
Cardium Announces Patent Wins Over Boston Scientific and Arch Development Corporation, Distinguishes Competitive Approach for the Treatment of Coronary Heart Disease
Devices Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Mar 2006
Cardium Announces Addition of Kelly D. Scott as Vice President of New Medical Technology Business
Devices Personnel
 HSMN NewsFeed - 9 Mar 2006
Cardium Acquires InnerCool Therapies, a Leading Provider of FDA-Cleared Therapeutic Hypothermia Systems
Devices Mergers & Acquisitions
 HSMN NewsFeed - 8 Mar 2006
Telzuit Medical Technologies, Inc. Signs Co-Marketing and Sales Agreement with Cardiomedics, Inc.
Devices Cardiology Monitoring
 HSMN NewsFeed - 31 Jan 2006
Study Results Indicate the CYPHER(R) Sirolimus-Eluting Coronary Stent May Reduce Re-Blockage and Chances of Major Side Effects in Patients with Complex Coronary Lesions
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 49

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 49 additional stories matching:
angina pectoris
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.